ViroGates A/S

CPSE:VIRO Stock Report

Market Cap: DKK 104.4m

ViroGates Management

Management criteria checks 2/4

ViroGates' CEO is Jakob Knudsen, appointed in Apr 2011, has a tenure of 13.58 years. directly owns 1.62% of the company’s shares, worth DKK1.69M. The average tenure of the management team and the board of directors is 6.7 years and 2.6 years respectively.

Key information

Jakob Knudsen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.6yrs
CEO ownership1.6%
Management average tenure6.7yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

Mar 06
ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Nov 21
We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

Jun 14
Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

Sep 19
We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Apr 14
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Dec 30
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Jakob Knudsen's remuneration changed compared to ViroGates's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-DKK 13m

Jun 30 2024n/an/a

-DKK 13m

Mar 31 2024n/an/a

-DKK 13m

Dec 31 2023n/an/a

-DKK 12m

Sep 30 2023n/an/a

-DKK 11m

Jun 30 2023n/an/a

-DKK 11m

Mar 31 2023n/an/a

-DKK 10m

Dec 31 2022DKK 2mDKK 1m

-DKK 10m

Sep 30 2022n/an/a

-DKK 12m

Jun 30 2022n/an/a

-DKK 13m

Mar 31 2022n/an/a

-DKK 16m

Dec 31 2021DKK 2mDKK 1m

-DKK 18m

Sep 30 2021n/an/a

-DKK 18m

Jun 30 2021n/an/a

-DKK 18m

Mar 31 2021n/an/a

-DKK 17m

Dec 31 2020DKK 2mDKK 1m

-DKK 19m

Compensation vs Market: Insufficient data to establish whether Jakob's total compensation is reasonable compared to companies of similar size in the Danish market.

Compensation vs Earnings: Jakob's compensation has been consistent with company performance over the past year.

CEO

Jakob Knudsen (56 yo)

13.6yrs

Tenure

DKK 1,601,492

Compensation

Mr. Jakob Knudsen serves as Independent Director at ExpreS2ion Biotech Holding AB (publ) since 2021. He had been Director at ExpreS2ion Biotech Holding AB (publ) since April 19, 2017 until 2021. Mr. Knudse...

Leadership Team

NamePositionTenureCompensationOwnership
Jakob Knudsen
Chief Executive Officer13.6yrsDKK 1.60m1.62%
DKK 1.7m
Jesper Eugen-Olsen
Co-Founder & Chief Scientific Officer24.8yrsno data3.37%
DKK 3.5m
Josephine Jorgensen
Chief Financial Officer1.7yrsno data0.016%
DKK 16.2k
May Dyvelkov
Vice President of Accounting5.1yrsno datano data
Thomas Krarup
Vice President of Global Sales & Marketing6.7yrsno data0.21%
DKK 217.6k
David Poulsen
Head of Marketingno datano datano data

6.7yrs

Average Tenure

61yo

Average Age

Experienced Management: VIRO's management team is seasoned and experienced (6.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Aaby
Scientific Advisorno datano datano data
Lars Kongsbak
Non-Executive Directorno dataDKK 106.25k0.090%
DKK 94.1k
Knut Borch-Johnsen
Scientific Advisor17.8yrsno datano data
Patrik Dahlen
Independent Chairman2.6yrsno data0.14%
DKK 142.7k
Valerie Soulier
Independent Director2.6yrsDKK 87.85kno data

2.6yrs

Average Tenure

62.5yo

Average Age

Experienced Board: VIRO's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.